Search research articles
Contact Us
Filters
Showing results (61-70 of 147) with videos related to
Page
of 15
Sort By:
Cancer Research
|
April 3, 2008
Signatures associated with rejection or recurrence in HER-2/neu-positive mammary tumors
Andrea Worschech, Maciej Kmieciak, Keith L Knutson, et al.
Scientific Reports
|
August 9, 2020
Dynamic control of tumor vasculature improves antitumor responses in a regional model of melanoma
Emmanuel M Gabriel, Minhyung Kim, Daniel T Fisher, et al.
Immunotherapy
|
April 5, 2019
Hypereosinophilia in a patient with metastatic non-small-cell lung cancer treated with antiprogrammed cell death 1 (anti-PD-1) therapy
Yanyan Lou, Julian A Marin-Acevedo, Prakash Vishnu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 15, 2004
Effect of dose on immune response in patients vaccinated with an her-2/neu intracellular domain protein--based vaccine
Mary L Disis, Kathy Schiffman, Katherine Guthrie, et al.
The American Journal of Pathology
|
November 10, 2011
LPS-induced murine systemic inflammation is driven by parenchymal cell activation and exclusively predicted by early MCP-1 plasma levels
Justin E Juskewitch, Bruce E Knudsen, Jeffrey L Platt, et al.
Gynecologic Oncology
|
January 29, 2008
Folate receptor alpha as a tumor target in epithelial ovarian cancer
Kimberly R Kalli, Ann L Oberg, Gary L Keeney, et al.
Surgical Oncology
|
August 30, 2024
Molecular markers of proliferation, DNA repair, and immune infiltration defines high-risk subset of resectable retroperitoneal sarcomas
Nathan D Seligson, Yan W Asmann, Tariq Almerey, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 10, 2011
Tumor-infiltrating programmed death receptor-1+ dendritic cells mediate immune suppression in ovarian cancer
James Krempski, Lavakumar Karyampudi, Marshall D Behrens, et al.
Journal of Translational Medicine
|
June 10, 2010
Vaccination with a plasmid DNA encoding HER-2/neu together with low doses of GM-CSF and IL-2 in patients with metastatic breast carcinoma: a pilot clinical trial
Håkan Norell, Isabel Poschke, Jehad Charo, et al.
Cytokine
|
March 7, 2015
Plasma immune analytes in patients with epithelial ovarian cancer
Matthew S Block, Matthew J Maurer, Krista Goergen, et al.
Page
of 15
Search research articles
Search
Showing results (61-70 of 147) with videos related to
Sort By:
Page
of 15
Cancer Research
|
April 3, 2008
Signatures associated with rejection or recurrence in HER-2/neu-positive mammary tumors
Andrea Worschech, Maciej Kmieciak, Keith L Knutson, et al.
Scientific Reports
|
August 9, 2020
Dynamic control of tumor vasculature improves antitumor responses in a regional model of melanoma
Emmanuel M Gabriel, Minhyung Kim, Daniel T Fisher, et al.
Immunotherapy
|
April 5, 2019
Hypereosinophilia in a patient with metastatic non-small-cell lung cancer treated with antiprogrammed cell death 1 (anti-PD-1) therapy
Yanyan Lou, Julian A Marin-Acevedo, Prakash Vishnu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 15, 2004
Effect of dose on immune response in patients vaccinated with an her-2/neu intracellular domain protein--based vaccine
Mary L Disis, Kathy Schiffman, Katherine Guthrie, et al.
The American Journal of Pathology
|
November 10, 2011
LPS-induced murine systemic inflammation is driven by parenchymal cell activation and exclusively predicted by early MCP-1 plasma levels
Justin E Juskewitch, Bruce E Knudsen, Jeffrey L Platt, et al.
Gynecologic Oncology
|
January 29, 2008
Folate receptor alpha as a tumor target in epithelial ovarian cancer
Kimberly R Kalli, Ann L Oberg, Gary L Keeney, et al.
Surgical Oncology
|
August 30, 2024
Molecular markers of proliferation, DNA repair, and immune infiltration defines high-risk subset of resectable retroperitoneal sarcomas
Nathan D Seligson, Yan W Asmann, Tariq Almerey, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 10, 2011
Tumor-infiltrating programmed death receptor-1+ dendritic cells mediate immune suppression in ovarian cancer
James Krempski, Lavakumar Karyampudi, Marshall D Behrens, et al.
Journal of Translational Medicine
|
June 10, 2010
Vaccination with a plasmid DNA encoding HER-2/neu together with low doses of GM-CSF and IL-2 in patients with metastatic breast carcinoma: a pilot clinical trial
Håkan Norell, Isabel Poschke, Jehad Charo, et al.
Cytokine
|
March 7, 2015
Plasma immune analytes in patients with epithelial ovarian cancer
Matthew S Block, Matthew J Maurer, Krista Goergen, et al.
Page
of 15